160 related articles for article (PubMed ID: 38108919)
1. Oral Anticoagulation for Atrial Fibrillation in Octogenarians Across the Renal Function Spectrum.
Carbone A; Bottino R; Attena E; Parisi V; Conte M; D'Andrea A; Imbalzano E; Alfredo C; Russo V
Cardiovasc Drugs Ther; 2023 Dec; ():. PubMed ID: 38108919
[TBL] [Abstract][Full Text] [Related]
2. Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.
Russo V; Attena E; Di Maio M; Mazzone C; Carbone A; Parisi V; Rago A; D'Onofrio A; Golino P; Nigro G
J Thromb Thrombolysis; 2020 Jan; 49(1):42-53. PubMed ID: 31385163
[TBL] [Abstract][Full Text] [Related]
3. Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF.
Harrington J; Carnicelli AP; Hua K; Wallentin L; Patel MR; Hohnloser SH; Giugliano RP; Fox KAA; Hijazi Z; Lopes RD; Pokorney SD; Hong H; Granger CB
Circulation; 2023 Jun; 147(23):1748-1757. PubMed ID: 37042255
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of oral anticoagulation among octogenarians with atrial fibrillation and anaemia.
Carbone A; Bottino R; Attena E; Parisi V; Conte M; D'Andrea A; Imbalzano E; Golino P; Russo V
J Thromb Thrombolysis; 2023 Feb; 55(2):222-227. PubMed ID: 36472719
[TBL] [Abstract][Full Text] [Related]
5. Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.
Russo V; Carbone A; Attena E; Rago A; Mazzone C; Proietti R; Parisi V; Scotti A; Nigro G; Golino P; D'Onofrio A
Clin Ther; 2019 Dec; 41(12):2549-2557. PubMed ID: 31735436
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and clinical predictors of inappropriate direct oral anticoagulant dosage in octagenarians with atrial fibrillation.
Carbone A; Santelli F; Bottino R; Attena E; Mazzone C; Parisi V; D'Andrea A; Golino P; Nigro G; Russo V
Eur J Clin Pharmacol; 2022 May; 78(5):879-886. PubMed ID: 35138442
[TBL] [Abstract][Full Text] [Related]
7. Impact of type of oral anticoagulants in patients with cerebral microbleeds after atrial fibrillation-related ischemic stroke or TIA: Results of the NOACISP-LONGTERM registry.
Wagner B; Hert L; Polymeris AA; Schaedelin S; Lieb JM; Seiffge DJ; Traenka C; Thilemann S; Fladt J; Altersberger VL; Zietz A; Dittrich TD; Fisch U; Gensicke H; De Marchis GM; Bonati LH; Lyrer PA; Engelter ST; Peters N
Front Neurol; 2022; 13():964723. PubMed ID: 36203998
[TBL] [Abstract][Full Text] [Related]
8. Vitamin K Antagonists and Direct Oral Anticoagulants in Nonagenarian Patients With Atrial Fibrillation.
Raposeiras-Roubín S; Alonso Rodríguez D; Camacho Freire SJ; Abu-Assi E; Cobas-Paz R; Rodríguez Pascual C; García Comesaña J; González-Carrero López A; Cubelos Fernández N; López-Masjuán Ríos Á; Cespón-Fernández M; Muñoz-Pousa I; Caneiro-Queija B; Rodríguez Albarrán A; Castañera SÁ; Guillén JV; Carpintero Vara A; Barreiro Pardal C; Domínguez-Erquicia P; Domínguez-Rodríguez LM; Díaz Fernández JF; Fernández Vázquez F; Iñíguez-Romo A
J Am Med Dir Assoc; 2020 Mar; 21(3):367-373.e1. PubMed ID: 31753740
[TBL] [Abstract][Full Text] [Related]
9. Prescription of DOACs in Patients with Atrial Fibrillation at Different Stages of Renal Insufficiency.
Hahn K; Lamparter M
Adv Ther; 2023 Oct; 40(10):4264-4281. PubMed ID: 37594666
[TBL] [Abstract][Full Text] [Related]
10. Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants.
Trevisan M; Hjemdahl P; Clase CM; de Jong Y; Evans M; Bellocco R; Fu EL; Carrero JJ
Am J Kidney Dis; 2023 Mar; 81(3):307-317.e1. PubMed ID: 36208798
[TBL] [Abstract][Full Text] [Related]
11. Comparison of prognostic impact of anticoagulants in heart failure patients with atrial fibrillation and renal dysfunction: direct oral anticoagulants versus vitamin K antagonists.
Sakai T; Motoki H; Fuchida A; Takeuchi T; Otagiri K; Kanai M; Kimura K; Minamisawa M; Yoshie K; Saigusa T; Ebisawa S; Okada A; Kitabayashi H; Kuwahara K
Heart Vessels; 2022 Jul; 37(7):1232-1241. PubMed ID: 35064298
[TBL] [Abstract][Full Text] [Related]
12. Mortality on DOACs Versus on Vitamin K Antagonists in Atrial Fibrillation: Analysis of the Hungarian Health Insurance Fund Database.
Papp T; Kiss Z; Rokszin G; Fábián I; Márk L; Bagoly Z; Becker D; Merkely B; Aradi D; Dézsi CA; Járai Z; Csanádi Z
Clin Ther; 2023 Apr; 45(4):333-346. PubMed ID: 37028991
[TBL] [Abstract][Full Text] [Related]
13. Direct Anticoagulants Versus Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation in a "Real-world" Nationwide Registry: Insights From the FANTASIIA Study.
Ortiz MR; Muñiz J; Esteve-Pastor MA; Marín F; Roldán I; Cequier A; Martínez-Sellés M; Saldivar HG; Bertomeu V; Anguita M
J Cardiovasc Pharmacol Ther; 2020 Jul; 25(4):316-323. PubMed ID: 32228180
[TBL] [Abstract][Full Text] [Related]
14. Renal Function and Clinical Outcomes Among Elderly Patients With Nonvalvular Atrial Fibrillation From ANAFIE.
Shimizu W; Yamashita T; Akao M; Atarashi H; Ikeda T; Koretsune Y; Okumura K; Suzuki S; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Morishima Y; Takita A; Inoue H
JACC Asia; 2023 Jun; 3(3):475-487. PubMed ID: 37396416
[TBL] [Abstract][Full Text] [Related]
15. Bleeding and thrombotic outcomes associated with postoperative use of direct oral anticoagulants after open peripheral artery bypass procedures.
Obi AT; Thompson JR; Beaulieu RJ; Sutzko DC; Osborne N; Albright J; Gallagher KA; Henke PK
J Vasc Surg; 2020 Dec; 72(6):1996-2005.e4. PubMed ID: 32278573
[TBL] [Abstract][Full Text] [Related]
16. Oral anticoagulation in very elderly patients with atrial fibrillation: Results from the prospective multicenter START2-REGISTER study.
Poli D; Antonucci E; Ageno W; Bertù L; Migliaccio L; Martinese L; Pilato G; Testa S; Palareti G
PLoS One; 2019; 14(5):e0216831. PubMed ID: 31120890
[TBL] [Abstract][Full Text] [Related]
17. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
Carnicelli AP; Hong H; Connolly SJ; Eikelboom J; Giugliano RP; Morrow DA; Patel MR; Wallentin L; Alexander JH; Cecilia Bahit M; Benz AP; Bohula EA; Chao TF; Dyal L; Ezekowitz M; A A Fox K; Gencer B; Halperin JL; Hijazi Z; Hohnloser SH; Hua K; Hylek E; Toda Kato E; Kuder J; Lopes RD; Mahaffey KW; Oldgren J; Piccini JP; Ruff CT; Steffel J; Wojdyla D; Granger CB;
Circulation; 2022 Jan; 145(4):242-255. PubMed ID: 34985309
[TBL] [Abstract][Full Text] [Related]
18. Relationship between the degree of renal dysfunction and the safety and efficacy outcomes in patients with atrial fibrillation receiving direct oral anticoagulants.
Wada R; Shinohara M; Nakanishi R; Kinosihita T; Yuzawa H; Ikeda T
J Arrhythm; 2021 Feb; 37(1):88-96. PubMed ID: 33664890
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation combined with chronic kidney disease: a systematic review and meta-analysis.
Li Y; Wu S; Zhou J; Zhang J
Thromb J; 2024 Apr; 22(1):40. PubMed ID: 38679736
[TBL] [Abstract][Full Text] [Related]
20. The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation.
van den Dries CJ; van Doorn S; Souverein P; Pajouheshnia R; Moons KGM; Hoes AW; Geersing GJ; van den Ham HA
TH Open; 2020 Oct; 4(4):e417-e426. PubMed ID: 33376941
[No Abstract] [Full Text] [Related]
[Next] [New Search]
